Medtronic Vascular designs and develops technologies for coronary, peripheral, and neurovascular indications. The company’s products include S7 Zipper MX Coronary Stent System, Clo-Sur PAD Nonwoven Hydrophilic Wound Dressing, Launcher Coronary Guide Catheter, and Stormer Over-the-Wire Balloon Dilatation Catheter. The company also offers Bridge Assurant Balloon-Expandable Stent Delivery System, GuardWire Plus Temporary Occlusion and Aspiration System, and S660 Coronary Stent. Medtronic Vascular was incorporated in 1991 and is based in Santa Rosa, California. As of January 29, 1999, Medtronic Vascular operates as a subsidiary of Medtronic.

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Jenscare Scientific Co., Ltd. is a holding company, which engages in the development and sale of transcatheter aortic valve systems. Its products include transcatheter prosthetic three tricuspid valve system and transcatheter aortic valve system. The company was founded on November 8, 2011 and is headquartered in Ningbo, China.

Biomet Biologics LLC engages in the design of biotechnology products. The company was founded on August 2, 2002 and is headquartered in Warsaw, IN.

InterVene is an up-and-coming medical device start-up company reinventing the way physicians treat severe venous disease in the legs. This technology represents the first-ever catheter-based, non-implantable approach, that allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their hearts. Millions of Americans currently suffer from painful venous stasis ulcers (VSUs) and other costly and devastating symptoms, yet no therapy currently exists to solve one of the most prevalent underlying causes: deep vein valve failure. InterVene plans to change that. The company's mission is to provide the first effective and widely utilized therapy for patients suffering from the painful and costly symptoms of Chronic Venous Insufficiency (CVI) due to deep vein reflux (DVR). It was founded in 2011 and is based in South San Francisco, CA, USA.

Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

Stentit BV develops and commercializes stents with regenerative capacity. The company was founded by Sol Cabrera and Bart Sanders and is headquartered in Eindhoven, the Netherlands.

Warwick Mills is an engineering of technical textiles for protective applications. They develop and integrate complex fiber composites for aerospace and outdoor applications. They provide textile manufacturing processes that include twisting, plying, warping, weaving, scouring, heat setting, coating, and lamination.

Grandhope Biotech Co., Ltd, a bio-tech company, develops, manufactures, and markets regenerative medical devices for the treatment of damaged tissue and organs in China. The company offers GrandNeuro membrane, an artificial dura patch for dura repairing; and NormalGEN, a type of biological dura repair patch manufactured from animal tissue used for the closure of dura mater during neurosurgery. It also provides ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; and DermalGEN, a wound dressing product for use on burns, scalds, and wounds due to skin loss or trauma.

T&R Biofab Co., Ltd engages in the manufacture and sale of biomedical equipment. It is specialized in bio-resorable mesh for tissue and organ regeneration. Its products include CMF Mesh, Nasal Mesh, Dental Membrane and Bio-resorable stent. The company was founded on March 11, 2013 and is headquartered in Siheung, South Korea.

OsteoBiologics is a biotechnology company. It engages in the development and manufacture of bio-absorbable polymeric scaffolds, films, and related instrumentations for the repair and replacement of bone, soft tissue, and articular cartilage. It provides ACTAEON, a tissue evaluation system, which determines the degree and scope of articular cartilage degeneration. It also manufactures custom parts. OsteoBiologics was founded in 1993 and is headquartered in San Antonio, Texas.

Regenerative Sciences, Inc. provides non-surgical joint repair services for orthopedic injuries. Its treatment areas include knee, hip, shoulder, spine, hand and wrist, foot and ankle, and elbow. The firm?s procedure Regenexx, is a non-surgical stem cell and blood platelet treatments to help heal damaged tissues, tendons, ligaments, cartilage, spinal disc, or bone. The company was founded by Christopher J. Centeno in 2005 and is headquartered in Broomfield, CO.

InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells – those that are extracted from and reintroduced into the same person – to promote healing.

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.

Flex Partners, Inc. designs and develops medical devices and instruments. It provides devices used for urological, cardiovascular, orthopedic, oral, and plastic surgical procedures. The firm's services include product prototyping, simulations and product testing, intellectual property development, validation and verification, program management, and business development. The company was founded in 1980 and is headquartered in Solana Beach, CA.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Beijing Meiyan Space Biomedical Co., Ltd, established on 2018-05-29, Business scope includes general items:Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail;Sales of hygiene products and single-use medical products;Import and export;Import and export agency;business management;Business Management Consulting.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Pharmaceutical commissioned production;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)